- In this section:
- Contact our JPT Peptide Technologies specialists
Benefits of using the PepMix Peptide Pools
• Simultaneous CD4 and CD8 response detection in a single sample (CEF pools: CD8 only)
• Better or equivalent T-cell response stimulation compared to whole protein antigens
• Improved and easier T-cell response detection in stored blood and PBMCs compared to whole protein antigens
• Reliable quality control and quality assurance
• High batch-to-batch reproducibility
• Prolonged shelf life when stored freeze-dried
• Pooled and aliquoted according to ISO 9001:2008 and GCLP regulations
Testimonials
"I have used JPT's peptide pools (PepMix) for years now, with great satisfaction! First CMV derived peptides and now also EBV. So far, we have published data in one publication and plan several more in the near future."
Anna Karin Lidehaell, Uppsala University, Clin. Immunol., Uppsala, Sweden
PepMix Peptide Pools applications
• Vaccine efficacy testing
• Antigen specific T-cell response measurement
• Antigen-specific T-cell responses correlation with immune status
• Antigen specific T-lymphocyte generation for adoptive immunotherapy
• T-lymphocyte epitope discovery
PepMix Peptide Pool Range
1. Positive and negative control pools
Including CEF, CEFT and EF Pools, HCMV (pp65, IE-1...), Human Actin
2. Infectious disease pools
Including EBV (EBNAs, BLZF1...), BKV (VP1, largeT...), Adenovirus, HPV, HIV, Influenza and many more
3. Tumour associated antigens
Including melanoma, prostate and breast cancer, glioma, gastric cancer, testicular/ovarian cancer, Wilms tumour and many more
Material available for download
Cytomegalovirus protein spanning PepMix peptide pools to discover changes in T cell immunity in the aging population
T cell therapy for viral infections after hematopoietic stem cell transplant
Qualification and use of peptide libraries for clinical trial immunomonitoring
Products
Note: product availability depends on country - see product detail page.
Details | Cat number & supplier | Size | Price |
PepMix Vaccinia virus (L3L) PM-VACV-L3L · JPT Peptide Technologies | PM-VACV-L3L JPT Peptide Technologies |
15 nmol (~25 µg) per peptide |
£645.00
15 nmol (~25 µg) per peptide
view
|
PepMix Vaccinia virus (MVA121L) PM-MVA-121L · JPT Peptide Technologies | PM-MVA-121L JPT Peptide Technologies |
2 vials |
£808.00
2 vials
view
|
PepMix Vaccinia virus (MVA074R) PM-MVA-074R · JPT Peptide Technologies | PM-MVA-074R JPT Peptide Technologies |
15 nmol (~25 µg) per peptide |
£696.00
15 nmol (~25 µg) per peptide
view
|
PepMix Vaccinia virus (MVA093L) PM-MVA-093L · JPT Peptide Technologies | PM-MVA-093L JPT Peptide Technologies |
15 nmol (~25 µg) per peptide |
£645.00
15 nmol (~25 µg) per peptide
view
|
PepMix Vaccinia virus (MVA189R) PM-MVA-189R · JPT Peptide Technologies | PM-MVA-189R JPT Peptide Technologies |
15 nmol (~25 µg) per peptide |
£598.00
15 nmol (~25 µg) per peptide
view
|
PepMix VZV (IE62)_2 subpools PM-VZV-IE62 · JPT Peptide Technologies | PM-VZV-IE62 JPT Peptide Technologies |
2 vials |
£937.00
2 vials
view
|
PepMix VZV (IE63) PM-VZV-IE63 · JPT Peptide Technologies | PM-VZV-IE63 JPT Peptide Technologies |
15 nmol (~25 µg) per peptide |
£645.00
15 nmol (~25 µg) per peptide
view
|
PepMix Yellow fever (NS4B) PM-YF-NS4B · JPT Peptide Technologies | PM-YF-NS4B JPT Peptide Technologies |
15 nmol (~25 µg) per peptide |
£645.00
15 nmol (~25 µg) per peptide
view
|